Representation of ChemomAb in a private investment round
Our firm represented ChemomAb Ltd., an Israeli biomed company, in a USD 10 million private investment round led by the entrepreneur Peter Thiel. For more information (Hebrew), click here.
Our firm represented ChemomAb Ltd., an Israeli biomed company, in a USD 10 million private investment round led by the entrepreneur Peter Thiel. For more information (Hebrew), click here.
Gilad Schiff, partner at our firm, and Alan G. Schwartz, partner at Wiggin and Dana, examine the differences in the legal process between Israel and the US in product liability cases.
The full article is available through the PDF icon.
Our firm represented Israeli businessman Teddy Sagi in an investment in Smartgreen. For the full article (Hebrew), click here.
Our firm represented Energean Israel Ltd, which holds the license for the Karish and Tanin offshore gas fields, in a major gas supply contract with companies from the The Israel Corporation group, valued at total USD 5.5 billion over 15 years. This transaction will have significant implications for the entire energy market in Israel. For more information (Hebrew), click here.
Our firm represented Amdocs, which, together with the Union Group owned by George Horesh, purchased land from Teva. Amdocs will invest $350 million in the construction of a campus on the land in Raanana. For more information (Hebrew), click here.
“Trump’s tax reform is expected to influence the considerations of Israeli start-up founders”. Itay Frishman, a partner in our firm, was interviewed for an article in “The Marker” on the subject and shared his experience with American investors investing in Israeli companies. For the full article (Hebrew), please click here.